发明名称 |
New water-soluble 2-(2,6-di:oxo-3-piperidinyl)-1H-iso-indole-1-di:one deriv. - may be administered parenterally and have comparable activity to thalidomide itself |
摘要 |
Thalidomide derivs. of formula (I) and/or their salts, in racemic or optically active form, are new R1, R2 = 1-6C alkyl; or R1 + R2 = CH2CH2XCH2CH2; R3 = H or Me; X = O or NH. USE/ADVANTAGE - (I) have immunosuppresive and immunomodulating activity comparable, at least, to thalidomide itself. (I) are more water-soluble than thalidomide so that lower side effects are to be expected. Admin. is esp. parenteral. For example, for treatment of leprosy, colitis ulceroso or graft-versus-host diseases, medicaments contg. (I) can be administered intravenously, intradermally, intramuscularly or intranasally.
|
申请公布号 |
DE4211812(A1) |
申请公布日期 |
1992.10.22 |
申请号 |
DE19924211812 |
申请日期 |
1992.04.08 |
申请人 |
GRUENENTHAL GMBH, 5100 AACHEN, DE |
发明人 |
EGER, KURT, PROF. DR., 7400 TUEBINGEN, DE;EHNINGER, GERHARD, PROF. DR., 7405 DETTENHAUSEN, DE;STUHLER, ALFRED, DR., 7902 BLAUBEUREN, DE |
分类号 |
A61K31/445;A61K31/4427;A61K31/5377;A61P31/04;A61P31/12;A61P37/00;A61P37/04;C07D401/04 |
主分类号 |
A61K31/445 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|